ABCL
ABCL
NASDAQ · Life Sciences Tools & Services

Abcellera Biologics Inc

$5.85
+0.11 (+1.92%)
As of Jun 23, 2:30 PM ET ·
Day Range $5.46 — $5.93
52W Range $2.75 — $6.79

Performance

1D
1W
1M
3M +74.63%
6M +69.57%
1Y +69.57%
YTD +70.55%
Open$5.46
Previous Close$5.74
Day High$5.93
Day Low$5.46
52W High$6.79
52W Low$2.75
Volume
Avg Volume5.01M
Market Cap1.69B
P/E Ratio
EPS$-0.48
SectorLife Sciences Tools & Services

Technical Indicators

Full analysis →
SMA 50 $3.99 Above
RSI (14) 58.5 Neutral

Analyst Ratings

Strong Buy
15 analysts
13 Buy 2 Hold 0 Sell
Price Target +666.0% upside
Current
$5.85
Target
$44.81
$32.90 $44.81 avg $56.58

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 77.50M 144.35M 396.65M
Net Income -151,060,854 -253,221,770 43.78M
Profit Margin -194.9% -185.1% 11.0%
EBITDA -201,106,311 -355,840,930 99.33M
Free Cash Flow 67.30M
Rev Growth -46.3% -46.3% +18.5%
Debt/Equity 0.27

Life Sciences Tools & Services Peers

Symbol Name Price Change P/E Mkt Cap
TMO Thermo Fisher Scientific Inc $469.35 +1.15% 25.2 172.66B
DHR Danaher Corp $178.97 +0.44% 34.0 125.40B
A Agilent Technologies Inc $126.67 +0.14% 25.4 35.89B
IQV Iqvia Holdings Inc $171.28 +2.07% 20.2 28.00B
MTD Mettler-Toledo International $1,156.64 -0.64% 26.4 23.13B
WAT Waters Corp $357.20 -0.29% 77.7 34.90B

Quick Stats

Market Cap1.69B
P/E Ratio
EPS$-0.48
Volume
SectorLife Sciences Tools & Services